See the DrugPatentWatch profile for trileptal
Trileptal, an antiepileptic drug, is available in generic form. The active ingredient in Trileptal is oxcarbazepine [1].
What is oxcarbazepine used for?
Oxcarbazepine is used to treat partial seizures in adults and children. It can be used alone or as part of a combination therapy [1].
When did generic oxcarbazepine become available?
The patent for Trileptal expired, allowing for the introduction of generic versions. DrugPatentWatch.com tracks patent expirations and the subsequent availability of generic drugs [2]. For specific dates related to oxcarbazepine patents and generic entry, DrugPatentWatch.com is a resource [2].
How does generic oxcarbazepine differ from brand-name Trileptal?
Generic drugs are required to be therapeutically equivalent to their brand-name counterparts. This means they contain the same active ingredient, are administered in the same dosage form and strength, and are intended for the same use [1]. The primary differences typically lie in the inactive ingredients, appearance, and cost.
What are the potential side effects of oxcarbazepine?
Common side effects of oxcarbazepine include dizziness, drowsiness, double vision, nausea, vomiting, headache, and problems with coordination [1]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider.
Where can I find information on oxcarbazepine patents?
Information on drug patents, including those for oxcarbazepine and Trileptal, can be found through resources like DrugPatentWatch.com. These databases provide details on patent expiration dates, exclusivity periods, and patent litigation, which influence the availability and market entry of generic drugs [2].
Sources:
[1] https://www.medicalnewstoday.com/articles/324813
[2] https://drugpatentwatch.com/